This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Sep. 12, 2012

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

ASCT Quality Assessment Center
American Society for Cytotechnology
The ASCT Quality Assessment Center is open for business! This new web-based educational resource center is organized by "workbenches," which are topics developed by cytotechnologists for cytotechnologists. They are designed to provide you with the tools and knowledge you need to manage the day-to-day operations of a modern cytology laboratory. The first workbench: The Lean Cytopathology Laboratory is now available for purchase. Additional workbenches will be available soon. Visit www.asct.com for more information and to register.



Viral loads have decreased in US patients with HIV
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The largest monitoring system for North American patients with HIV showed a 9 percent increase in the number of patients treated with highly active antiretroviral therapy from 2000 to 2008, and a 26 percent increase in the number of patients with HIV who had a reduced viral load, in what may be the first report of national trends in antiretroviral treatment, according to findings published in the Annals of Internal Medicine. More

UPCOMING EVENTS





Event       Location     Dates Notes

California Association of Cytotechnologists
Annual Seminar/Workshop
      Crowne Plaza,
      Irvine, Calif.
   Sept. 15 For more information contact Matt Riding at president@cacstate.org

Pathology Update 2012
“New Roles for Pathologists in the Era of Health Care Reform”
      University of
      Vermont/Fletcher
      Allen Health Care,
      Burlington, Vt.
   Sept. 22 For more information, contact Lisa Kapoor at lisa.kapoor@vtmednet.org

SOP: An Important Form of Laboratory Communication       Your PC    Sept. 25
   2 p.m. EST
Debora A. Smith, CT (ASCP)
Cytology Supervisor, The Methodist Hospital, Houston, Texas
More details | Register

St. Louis Society of Cytology Conference       Norwood Hills
      Country Club,
      St. Louis, Mo.
   
   Sept. 29
   
More information

Wisconsin Society of Cytology Conference       Country Springs
      Hotel
      Pewaukee, Wis.
   
   Oct. 13
   
More information

The ASCT 2012-2013 membership year has started! Renew your membership Here.



INDUSTRY NEWS


EU advises all girls need cervical cancer vaccines
Reuters via Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
All girls in Europe should be immunized against the human papillomavirus and current vaccine coverage rates are far too low, European Union health officials have announced. In new advice about tackling the virus, the European Center for Disease Prevention and Control said that while 19 out of 29 countries in the region had introduced HPV vaccine programs, vaccination rates were as low as 17 percent in some. More

Colon cancer harder to detect in women
The San Diego Union-Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Colon cancer is the second leading cause of cancer death in the United States, and in this year alone, the Centers for Diseases Control and Prevention estimates that 143,460 people will develop colorectal cancer. The lifetime risk of developing colon cancer in this country is one in 20 (5 percent), which is quite an astounding number. Both men and women seem to be affected about equally. More

Polymer nanoparticle overcomes anticancer drug resistance
PhysOrg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a nanotechnology two-for-one, researchers at the Johns Hopkins University Center of Cancer Nanotechnology Excellence have created a polymer nanoparticle that overcomes tumor resistance to the common anti-cancer agent doxorubicin and that protects the heart against drug-triggered damage, a therapy-ending side effect that limits doxorubicin's effectiveness. This novel nanoparticle incorporates both doxorubicin and curcumin, a major component of the bright yellow spice turmeric. More

MORE NEWS


US health panel likely to make HIV tests routine
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A U.S. health panel may soon make HIV testing as standard a practice as checking cholesterol levels, a move that would fundamentally change how the virus is detected and treated. The U.S. Preventive Services Task force, a government-backed group of clinicians and scientists, is expected to make a new recommendation on HIV screening available for public comment before the end of the year. More

Court rules controversial stem cell research is legal
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The federal government may continue to pay for controversial human embryonic stem cell research, a federal appeals court ruled. The three-judge panel says the government has correctly interpreted a law that bans the use of federal funds to destroy human embryos for research. The ruling is unlikely to put the issue to rest and one of the judges pleaded for Congress to make clear what the government should and should not be able to do. More

Bits of mystery DNA, far from 'junk,' play crucial role
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Among the many mysteries of human biology is why complex diseases like diabetes, high blood pressure and psychiatric disorders are so difficult to predict and, often, to treat. An equally perplexing puzzle is why one individual gets a disease like cancer or depression, while an identical twin remains perfectly healthy. Now scientists have discovered a vital clue to unraveling these riddles. More

New tick-borne virus puts the bite on Missouri farmers
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When two Missouri farmers wound up hospitalized with fever, fatigue, low blood cell counts and elevated liver enzymes in 2009, doctors suspected ticks were to blame. The men had all the symptoms of ehrlichiosis, a potentially dangerous bacterial infection spread by, yes, ticks. But when scientists cultured samples of the farmers' blood, the bacteria were nowhere to be found. More

Drug-resistant malaria vexes health workers in Cambodia
Voice of America    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A little-known battle being fought in Cambodia could have global ramifications. The fight is against drug-resistant malaria. The problem is more severe in Cambodia than anywhere else in the world, says Steven Bjorge, the World Health Organization's malaria team leader in Cambodia. More

Alarming levels of drug-resistant TB found worldwide
Reuters via NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have found an alarming number of cases of the lung disease tuberculosis in Africa, Asia, Europe and Latin America that are resistant to up to four powerful antibiotic drugs. In a large international study published in the Lancet medical journal, researchers found rates of both multi drug-resistant TB and extensively drug-resistant TB were higher than previously thought and were threatening global efforts to curb the spread of the disease. More

West Nile infections rise as outbreak spreads to northern states
Bloomberg Businessweek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The worst-ever U.S. outbreak of West Nile virus is spreading across the U.S. with a 25 percent increase in the number of people infected by the mosquito-borne disease, health officials said. There were 87 deaths among 1,993 cases of the disease reported this season, the Centers for Disease Control and Prevention said. The cases have increased the most in the northern U.S., with 44 states having at least one human infection, said Lyle Petersen, director of the division of vector-borne infectious disease at the CDC. More

'Fortunate to be alive': Girl, 7, contracts bubonic plague at Colorado campground
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A 7-year-old girl is recovering at a Denver hospital from a rare case of bubonic plague she likely contracted from fleas from a dead squirrel at a southwestern Colorado campground, hospital officials said. Sierra Jane Downing is "fortunate to be alive," but is on the road to recovery after her near-fatal bout with the disease, the Rocky Mountain Hospital for Children said in a statement. It is the first confirmed case of bubonic plague in Colorado since 2006, the hospital said. More


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Sept. 5, 2012
Aug. 22, 2012
Aug. 8, 2012
July 25, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063